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Abstract
Background and aims: Inflammatory bowel disease (IBD) can be associated with nutritional problems. The aim of
this study was to investigate diet and nutritional status of IBD patients.
Methods: A total of 78 participants (35 men and 43 women aged 18–74 years) were included in this cross-sectional
study. The majority (80 %) of the participant received infliximab treatment. Participants filled out disease related
questionnaires and 31 participants also a 3-day food record. Body composition was measured and blood samples
analysed in order to estimate nutritional status.
Results: The majority (87 %) claimed that diet affects digestive tract symptoms and 72 % had changed diet
accordingly. The most common foods restricted were dairy products (60 %), processed meat (55 %), soft drinks
(46 %), alcohol (45 %) and fast food (44 %). Body mass index was mostly in the overweight range but 46 % of the
participants had been diagnosed with some nutritional deficiency since IBD diagnosis (most common was iron
deficiency: 39 %). Patients who restricted meat products had lower ferritin values (48 ± 39 vs. 95 ± 74 μg/L, P = 0.011).
Intake of vitamin D and calcium were not adequate (65 % below recommeded intake for both) and 60 % had poor
vitamin D status.
Conclusion: IBD patients often change their dietary intake in order to affect digestive tract symptoms. Many patients
have a history of nutrient deficiency. Restriction of dairy and meat consumption is common and is negatively
associated with intake or status of micronutrients like calcium and iron. Dietary advice by a dietitian and use of
potentially helpful dietary supplements is indicated.
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Background
Patients with Inflammatory bowel disease (IBD), both
with Crohn’s disease (CD) and ulcerative colitis (UC), have
abdominal symptoms that can both affect the intake and
absorption of nutrients [1]. After diagnosis of IBD the
disease process can lead to many nutritional challenges,
both during remission and relapses. Decreased dietary
intake, nutrient malabsorption, macro- or micronutrient
deficiencies, weight loss and osteoporosis are some of the
nutritional challenges people have to face [2, 3].
It is not uncommon that patients associate certain
foods or food groups with exacerbation of symptoms in
their digestive tract and therefore avoid certain types of
foods and beverages. As a consequence, studies have
been conducted to find out what food types are related
to symptoms in patients [4, 5]. However, it has been diffi-
cult to generalize findings, because some food items re-
ported to be beneficial for one patient can be detrimental
to another patient [4]. Thus, it is rarely possible to identify
a specific group of food items that should be avoided by
all patients and thus a personalized diet is important in
the management of these individuals [6].
As patients frequently avoid certain food groups, patients
might be at risk of insufficient dietary intake. Furthermore,
some of patients with IBD, particularly those from Crohn’s
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disease even suffer from nutritional deficiencies especially
associated with malabsorption. Therefore, not surprisingly,
micronutrient deficiency in IBD is common and well docu-
mented for iron, folic acid and vitamin B12 [7]. Iron defi-
ciency is considered the most common micronutrient
deficiency, reported in up to 39 % of IBD patients [8] and
with up to 65 % of patients requiring iron replacement over
the course of their disease [9]. Vitamin B12 deficiency ap-
pears to be common in patients with ileal CD or resection
of the ileum [10] and prevalence of subnormal levels of
vitamin B12 has been reported in 18 % of IBD patients [8].
Restriction of dairy products seems to be quite common
among IBD patients or up to 65 % [11]. As a possible con-
sequence, inadequate calcium intake has been reported in
one third of patients [12] along with inadequate intake of
vitamin D (36 %) [8] and low serum vitamin D concentra-
tions [13]. This can be clinically relevant as osteoporosis
has been reported among these patients [14–18] and
fracture among patients with IBD is 40 % greater than
in general population [19].
In order to gain more knowledge on IBD and diet, the
aim of the present study was to investigate dietary in-
take, food preferences and nutritional status of Crohn’s
disease and ulcerative colitis patients in Iceland.
Material and methods
Participants and study design
This cross-sectional study included 78 patients (35 men
and 43 women aged 18–74 years) with the diagnosis of
either Crohn’s disease or ulcerative colitis. The data col-
lection was carried out from April 2013 to January 2014.
The participants were recruited by advertisements from
all over Iceland but most of them were from the Reykjavik
capital area. The sample size was not based on sample
size/power calculations, but rather presents the number of
available patients in the Reykjavik area willing to partici-
pate. Most of the participants (n = 62) were on treatment
with infliximab therapy receiving infusion every five to
eight weeks. The rest of the participants (n = 16) used
other IBD drugs or no medicines at all. The vast majority
of patients were in clinical remission, as assessed by their
responsible physician.
Ethics, consent and permissions
The study was approved by the Icelandic National Bio-
ethics Committee (VSN-2013020067/0307) and all per-
sons gave their informed consent prior to their inclusion
in the study.
Questionnaire
Participants answered a questionnaire which contained
65 questions about the disease, symptoms, medications,
allergies, supplementations, diet and food preferences.
Body composition measures
Body weight was measured on a calibrated scale (model
no. 708, Seca, Hamburg, Germany) and height was mea-
sured with a calibrated stadiometer (model no. 206;
Seca, Hamburg, Germany). Body mass index (BMI) was
calculated from the recorded height and weight. Waist
circumference was measured halfway between the top of
the lateral iliac crest and the lowest rib. Body fat% was
assessed by bioelectrical impedance analysis (Body Fat
Monitor BF 306, Omron Healthcare UK Ltd, Milton
Keynes, United Kingdom).
Blood samples
Blood samples were taken from 62 patients by the nurses
in the hospital prior to the infusion of infliximab. The
blood values obtained in the present study were the fol-
lowing: hemoglobin, albumin, C-reactive protein (CRP),
iron, total iron binding capacity (TIBC), ferritin, vitamin
B12, folate and 25-OH vitamin D (25OHD). Blood samples
were not available from patients that used other IBD drugs
than infliximab or no medicines at all.
Dietary assessment
The participants recorded intake of all food, drinks and
dietary supplements during three days including one
weekend day (n = 31). The data was transferred into a
nutrient calculation program, ICEFOOD version 2.0 which
is based on the Icelandic nutrient composition database
ISGEM. The average intake of three days for each partici-
pant was calculated. The authors want to comment here
that a 7 day food record would have been more preferable,
however, experience has hown that even a 3 day record is a
considerable threshold for subjects to participate.
Data analysis
Statistical analyses were performed using SPSS 20 (SPSS
Inc., Chicago, IL, USA). Data are described as mean ±
standard deviation (SD) or as median and inter-quartile-
range (IQR). Data were checked for normal distribution
using the Kolmogorov-Smirnov test. An independent
samples t-test (normal distribution) or a Mann-Whitney
U test (non-normal distribution) was used to assess the
difference between two groups. The level of significance
in the study was P < 0.05.
Results
A total of 78 patients (35 men and 43 women aged 18–74
years) with the diagnosis of either Crohn’s disease (55 %)
or ulcerative colitis (45 %) were recruited from the out-
patient clinic and participated in the study. Table 1 shows
the characteristics of the participants. The mean BMI for
both genders was in the overweight range, only one man
(2.9 %) and one women (2.3 %) were with a BMI below
18.5 kg/m2. The majority of the participants had changed
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their diet during the course of the disease and also the ma-
jority claimed that diet affects digestive tract symptoms.
Foods and beverages most frequently claimed to have
negative effects on symptoms and thus avoided were dairy
products (60 %), processed meat (55 %), soft drinks (46 %),
alcohol (45 %), fast food (44 %), spicy food (41 %), citrus
fruits (41 %), cabbage (26 %), meat (26 %) and coffee/tea
(36 %). Foods that were mentioned to have positive effects
on symptoms were fish (22 %), non-processed food (8 %),
chicken (6 %), and nutritional drinks (6 %). Fruits and veg-
etables were both mentioned to have negative as well as
positive effects but slightly more people found them nega-
tive or 16.5 % vs. 13.5 %.
The use of dietary supplements among participants is
shown in Table 2. Cod liver oil and vitamin D supple-
ments were the most commonly used supplements. Al-
though 47 patients (60 %) reported to consume less or
even no dairy products, but only 8 of them used calcium
supplements. Dietary calcium intake of 72 % of those
who restrict dairy products did not reach the recom-
mended daily intake of 800 mg/d.
Almost half of the participants (46 %) had been diag-
nosed with a nutritional deficiency after their diagnosis
of CD or UC. Iron deficiency was the most frequent de-
ficiency (39 %) which was more frequent in women
younger than 50 years than in women older than 50 years
or in men (58 vs. 25 % vs. 26 %, respectively, P = 0.015).
Previous diagnose of deficiency of vitamin B12 (17 %),
vitamin D (4 %) and folic acid (1 %) were less common.
Table 3 shows the participants’ dietary intake (from food
and dietary supplements) in comparison to the Nordic
Nutrition Recommendations 2012 [20] and to results from
the Icelandic National Dietary Survey from 2011 [21].
Analysis of the micronutrient and vitamin intake shows
that intake was below recommended levels, especially true
for women. e.g., 65 % of the participants had a calcium in-
take below 800 mg/d and 16 % even below 400 mg/d.
When the daily intake of vitamin D was examined we
found out that 65 % did not reach the Icelandic recom-
mendations and 29 % were even below 2.5 μg/d, which is
the lower level of intake for vitamin D. Seventy-seven% of
women did not reach the recommended daily intake of
iron. Vitamin B12 intake however was sufficient, but
participants who reduced intake of milk products had
less intake of vitamin B12 (4.7 ± 3.0 vs. 9.4 ± 8.2 μg B12/day,
P = 0.042).
In Table 4, the results of blood samples of the partici-
pants are demonstrated. Women were more often below
reference values in various iron indices (iron: 22 % vs.
3 %, P =0.06; ferritin: 18.5 % vs. 0 %, P = 0.009). Partici-
pants who reduced meat intake in course of their disease
had lower blood values of ferritin compared to others
(47.5 ± 38.6 vs. 95.1 ± 73.5, P = 0.011). This difference
was still significant after correction of age and gender.
Although only the minority of participants had re-
ceived a diagnosis of vitamin D deficiency previously
(see above), the measured 25OHD concentrations were
low and 60 % of the participants were below 50 nmol/L
and 26 % even below 30 nmol/L. Participants taking
vitamin D supplements had as might be expected higher
levels of vitamin D than those not taking any vitamin D
supplements (70.6 ± 40.5 vs. 41.8 ± 21.2 nmol/L, P = 0.007).
There was not a clear association between 25OHD status
and weeks of the year and no association between in-
take of cod liver oil and 25OHD status (data not shown).
Similarly,patients who recieved vitamin B12 supplements
had higher vitamin B12 blood values those who did not
(505 ± 215 vs. 361 ± 99 pmol/L, P = 0.001).
Discussion
The results of the current study showed that patients as-
sociate certain food groups to digestive tract symptoms.
The vast majority of the participants (87 %) claimed that
diet can affect these symptoms and 72 % have changed
their diet accordingly after they were diagnosed with IBD.
The most common food groups mentioned to worsen
symptoms were dairy products, processed meat, fast food,
Table 1 Characteristics of the participants
All (N = 78) Males (n = 35) Females (n = 43)
Age 40 ± 12.7 39 ± 10.8 41 ± 14.0
Height (cm) 173 ± 8.7 179 ± 6.9 168 ± 5.9a
Body Weight (kg) 79.2 ± 16.4 82.1 ± 16.1 76.9 ± 16.5
BMI (kg/m2) 26.5 ± 5.4 25.5 ± 4.6 27.4 ± 5.9
Waist (cm) 92.6 ± 13.3 93.3 ± 11.6 92.2 ± 14.6
Body fat (%) 29.4 ± 9.9 22.4 ± 7.8 36.2 ± 6.4
Crohn’s disease 43 (55 %) 22 (63 %) 21 (49 %)
Ulcerative Colitis 35 (45 %) 13 (37 %) 22 (51 %)
Infliximab/Adalimumab 65 (83 %) 35 (100 %) 30 (70 %)a
Have met a dietitian 32 (41 %) 13 (37 %) 19 (44 %)
Smokers 16 (21 %) 9 (26 %) 7 (16 %)
Data are presented as mean ± SD or as N and % of all, males and females
Abbreviations: BMI body mass index, SD standard deviation
asignificantly different from male participants
Table 2 Current intake of supplements among participants
All (N = 78) Male (n = 35) Female (n = 43)
Cod liver oil 48 (62 %) 23 (66 %) 25 (58 %)
Vitamin D 32 (41 %) 11 (31 %) 21 (49 %)
Multivitamin 21 (27 %) 6 (17 %) 15 (35 %)
Vitamin B-12 14 (18 %) 5 (14 %) 9 (21 %)
Calcium 12 (15 %) 3 (9 %) 9 (21 %)
Iron 12 (15 %) 2 (6 %) 10 (23 %)a
Probiotics 10 (13 %) 3 (9 %) 7 (16 %)
Data are presented as N and % of all, males and females
asignificantly different from male participants
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soft drinks, alcoholic beverages but also citrus fruits and
cabbage. However, due to inter-individual variability, i.e.,
some foods are mentioned as having both negative as well
as positive effects on the disease. Thus it is very difficult to
give general dietary advice for this patient group.
Body composition can change as a consequence of
IBD. Thus, patients with IBD should routinely have their
body weight measured [22] as the prevalence of protein-
energy malnutrition has been reported to be 20–85 %
[7]. Interestingly, the prevalence of malnutrition accord-
ing to BMI has decreased over the years as indicated by
recent studies showing lower prevalence rates in IBD pa-
tients [23] which may be related to improved therapy
that can induce disease remission and keep the patients
in remission. Most patients in the present study had
BMI even in the overweight range. The reported mean
intakes of macronutrients (E%) were comparable to the
results from the Icelandic National Dietary Survey [21]
and in line with the Nordic nutrition recommendations
2012 [20], with the exceptions of carbohydrates, which
deliver less than 45 % of energy, and fibre. Although en-
ergy intake of the participants seemed to be satisfying,
both in terms of BMI and estimated intake of macronu-
trients, nearly half of the participants (46 %) have been
diagnosed with some nutritional deficiency during their
history of IBD. In clinical practice, micronutrient deficiency
Table 3 Mean intake (food and supplements) of macronutrients and median intake of dairy products, calcium, vitamin D, iron and
vitamin B12 per day
(n = 31) mean ± SD %E Recomended %Ea National survey 2012b
Energy (kcal) 1860 ± 715 2059 kcal
Protein (g) 87 ± 36 19 % 10–20 % 93 g (18 %)
Fat (g) 73 ± 33 35 % 25–40 % 83 g (36 %)
Carbohydrates (g) 195 ± 82 42 % 45–60 % 216 g (42 %)
Fibre (g) 17.5 ± 6.7 2 % 23 g 17 g (1.7 %)
Added sugar (g) 38.5 ± 34.7 8 % >10 % 47 g (9 %)
median (IQR) Male (n = 14) Female (n = 17) RDIa mean ± SD
Dairy products (g) 190 (232) 218 (550) 133 (95.3) – 300 ± 232
Calcium (mg) 717 (302) 877 (718) 674 (204) 800 923 ± 428
Vitamin D (μg) 6.5 (18.6) 13.1 (17.3) 4.3 (13.2) 10/15b 8.1 ± 9.3
Iron (mg) 10.8 (8.4) 11.5 (10) 8.5 (7.5) 9c/15d 10.9 ± 5.8
Vitamin B12 (μg) 5.1 (5.7) 7.2 (6.7) 4.3 (4.8) 2.0 6.9 ± 8.5
Abbreviations: SD standard deviation, %E % of total energy, RDI recommended daily intake
aAccording to Nordic Nutrition Recommendation 2012
bAccording to the Icelandic National Dietary Survey 2010–2011
cMale
dFemale
Table 4 Results of blood samples of the participants
All (N = 64) Male (n = 35) Female (n = 29) Reference ranges
Hemoglobin (g/L) 139 ± 14.2 148 ± 9.5 128 ± 11.3a 134–171b/118–152c
Albumin (g/L) 41 ± 3.7 42 ± 3.3 40 ± 3.8a 36–48
CRP (mg/L) 8.3 ± 7.8 6.9 ± 5.4 10 ± 9.8 <10
Iron (μmol/L) 17.9 ± 8.1 19.6 ± 7.8 15.7 ± 8.1 9–34
TIBC (μmol/L) 61.3 ± 14.3 58.3 ± 15 64.9 ± 12.9 49–83
Ferritin (μg/L) 81.9 ± 68.8 100 ± 66.7 58.4 ± 65.2a 30–400b/15–150c
Vitamin B12 (pmol/L) 385 ± 133.8 385 ± 134 384 ± 137 210–800
Folate (nmol/L) 23 ± 10.3 23.4 ± 10 22.6 ± 10.6 6–35
Vitamin Dd (nmol/L) 51.9 ± 32.2 47.5 ± 33 57.5 ± 30.4 50–150
Data are presented as mean and SD
Abbreviations: SD standard deviation, CRP C-reactive protein, TIBC total iron binding capacity
asignificantly different from male participants
bMale
cFemale
d25OHD
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in IBD is common but in most cases it does not tend to
have any clinical manifestation except with regard to iron,
folic acid and vitamin B12 [7].
In general, patients with IBD are at greater risk of de-
veloping metabolic bone disease as high prevalence of
osteoporosis has been reported among these patients
[14–17]. In the current study more than half of the par-
ticipants restricted their intake of dairy products which
is similar to recently published findings from Brasil-
Lopes et al. [11]. Thus, not surprisingly, dietary calcium
intake was found to be inadequate in this group and
72 % did not achieve recommended intake. Unfortunately,
only 15 % of those who restrict their dairy intake took
calcium supplements.
Another important nutrient to ensure good bone
health is vitamin D. An intervention study showed that
use of calcium and vitamin D supplements has positive
effects on bone health in IBD [24]. Forty-one percent of
our participants used vitamin D supplements and these
individuals have significantly higher 25OHD concentra-
tions than those who do not take supplements. Even more
frequently (62 %) cod liver oil was used on a regular basis.
This is higher than the numbers from the Icelandic
National Dietary Survey [21], according to which 43 %
of adults in Iceland take cod liver oil [21]. However, in
our study there was no significant association between
intake of cod liver oil and 25OHD status indicating that
amount and/or frequency of cod liver oil used are not al-
ways sufficient. Inadequate uptake of micronutrients from
the intestinal tract can occur in IBD patients but mostly in
those with active disease [25]. However, the vast majority
of the patients in the present study were in clinical and
biochemical remission.
Nearly two thirds of the patients had 25OHD below the
threshold of 50 nmol/L. Considering previous Icelandic
studies on vitamin D, it shows that in our participants
there was a similar or somewhat higher prevalence of
inadequate 25OHD (60 %) as compared to community
dwelling old adults (41–50 %) [26], geriatric hospitalized
patients (56 %) [27] and young adults (61 %) [28]. Consid-
ering this low intake of dairy products along with low
25OHD levels, more supervision and education/guidance
to the patients seems to be of importance in order to re-
duce the risk osteoporosis can be considered as beneficial.
Iron deficiency had been detected in 39 % of the par-
ticipants (58 % in women younger than 50 years) since
the diagnosis of IBD. This is in accordance with previous
studies which reported iron deficiency the most com-
mon micronutrient deficiency [8] and with up to 65 % of
patients requiring iron replacement over the course of
their disease [9]. The associated anemia is clinically im-
portant and can affect quality of life [25]. Despite the high
prevalence of iron deficiency in IBD, only 15 % of our
participants were on iron supplements. Interestingly, iron
intake was not significantly different between patients who
restricted meat and meat products in comparison with
those who did not. However, ferritin values were signifi-
cantly lower in those who did not eat meat. It is well
known that iron bioavailability from meat is usually better
than from plant sources [29].
Dietary intake of vitamin B12 was high both for men
and women. The participants who reduced intake of
milk products had lower intake of vitamin B12 than
those who did not reduce milk intake but still higher
than the recommended intake. This can be partly ex-
plained by the fact that milk products contribute to vita-
min B12 intake and according the latest national dietary
survey in Iceland this contribution is 15 % [19]. Mean
vitamin B12 levels in blood were well above the recom-
mended minimum.
Dietary supplements have been discussed or suggested
for IBD patients in order to make up for a deficiency or
to prevent a deficiency from occurring. Supplements that
may be needed include among others calcium, vitamin D,
iron, vitamin B12 and folate. However, before taking dietary
supplements, several issues have to be considered. Vitamin
and mineral supplements can cause GI symptoms. Supple-
ments can contain lactose, artificial colors, sugar alcohol or
preservatives which IBD patients can react to. It is thus in-
dicated to discuss all dietary supplements with members of
the health care team [30].
Limitations
This study was of cross-sectional nature and thus cannot
differentiate between cause and effect in an observed
association. Further on, we used subjective information
from patients, e.g., food groups and digestive tract symp-
toms, which cannot be considered proof for a causal rela-
tion between e.g., milk and symptoms. Rather we used this
information to detect potential nutrition related problems,
e.g., poor calcium intake, derived from avoidance of certain
food groups. Also, this is a selected group of IBD patients,
mostly on biological treatment and most in clinical remis-
sion. Therefore we can not extrapolate the results of or
study into an unselected group of IBD patients and not on
those with active disease, who probably are more affected
by nutritional deficiency.
Conclusion
Our study showed that IBD patients often change their
dietary intake in order to affect digestive tract symptoms.
Many patients have a history of nutrient deficiency. Re-
striction of dairy and meat intake was common and can
negatively influence intakes or status of micronutrients
like calcium and iron. Dietary advice by a dietitian and
use of potentionally helpful dietary supplements is often
indicated.
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